Pressure BioSciences, Inc. Stock
Stocks
PBIO
US74112E2081
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
20:43:58 23/03/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.000500 USD | -.--% |
|
+25.00% | - |
| Market Cap | 143K 124K 116K 106K 199K 13.7M 200K 1.37M 536K 6.92M 538K 527K 22.94M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 19.77M 18.54M 16.92M 31.88M 2.19B 31.99M 220M 85.82M 1.11B 86.16M 84.28M 3.67B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 week | +25.00% | ||
| Current month | -28.57% | ||
| 1 month | -28.57% | ||
| 3 months | -58.33% |
| 1 month | 0 |  | 0.1 |
| Current year | 0 | | 0.1 |
| 1 year | 0 | | 0.2 |
| 3 years | 0 | | 0.8 |
| 5 years | 0 | | 2.85 |
| 10 years | 0 | | 13.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/2004 | |
| Chief Tech/Sci/R&D Officer | 61 | 03/04/2006 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 24/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 01/01/1992 | |
Jeffrey Peterson
CHM | Chairman | 70 | 08/08/2012 |
Michael Urdea
BRD | Director/Board Member | 73 | 08/02/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/27/24 A | Others | Chief Executive Officer | 22,878 | 0.0659% | ||
| 9/27/24 A | Others | Chairman | 59,652 | 0.1719% | ||
| 9/27/24 A | Others | Chief Technology Officer | 18,863 | 0.0543% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +25.00% | +400.00% | -99.80% | 17.19K | |
| -1.35% | -1.13% | +26.27% | +12.02% | 230B | |
| +0.18% | -1.27% | +4.98% | -18.16% | 152B | |
| +1.51% | -1.64% | -21.28% | +20.04% | 132B | |
| +0.36% | -7.01% | -55.60% | -14.34% | 67.88B | |
| +0.29% | +0.47% | +10.90% | +15.91% | 52B | |
| +0.66% | -1.69% | -16.47% | -14.35% | 51.05B | |
| -2.44% | -3.25% | +22.43% | +26.08% | 43.38B | |
| -1.56% | +0.97% | +37.41% | +44.08% | 40.74B | |
| +1.94% | +3.81% | -12.45% | +46.61% | 34.67B | |
| Average | -0.04% | -0.75% | +39.62% | +1.81% | 80.33B | |
| Weighted average by Cap. | -0.14% | -1.29% | +2.51% | +7.86% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.49M 1.4M 1.28M 2.4M 165M 2.41M 16.58M 6.47M 83.43M 6.49M 6.35M 277M | 1.98M 1.7M 1.6M 1.46M 2.75M 189M 2.76M 18.96M 7.4M 95.42M 7.43M 7.26M 316M |
| Net income | -16.08M -13.85M -12.99M -11.86M -22.34M -1.54B -22.41M -154M -60.13M -776M -60.36M -59.05M -2.57B | -29.31M -25.26M -23.68M -21.62M -40.73M -2.8B -40.86M -281M -110M -1.41B -110M -108M -4.69B |
| Net Debt | 20.53M 17.69M 16.58M 15.14M 28.52M 1.96B 28.61M 197M 76.76M 990M 77.06M 75.39M 3.28B | 22.8M 19.65M 18.42M 16.82M 31.68M 2.18B 31.79M 219M 85.29M 1.1B 85.62M 83.76M 3.65B |
Employees
16
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- PBIO Stock
Select your edition
All financial news and data tailored to specific country editions
